For the Inventor, By the Inventor

Enter assignee name

Daejeon, South Korea

Neopharm Co., Ltd.

Calculating rank

USPTO Granted Patents = 20

% Expired Patents = 10.0

EPO Patents = 6

Trademarks = 7

Forward Citations = 22

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

Bu-Mahn Park (11 out of 11 patents)

Hye Seong Shin (9 out of 9 patents)

Kyung Sook Yoo (8 out of 8 patents)

4. Se Kyoo Jeong (7 out of 9 patents)

5. Sung Woo Kim (4 out of 12 patents)

6. Yu Ra Jung (4 out of 4 patents)

7. Minhee Kim (3 out of 3 patents)

8. Yoon Ho Kim (3 out of 27 patents)

9. Eunkyung Lee (3 out of 28 patents)

10. Jeong Eun Jeon (3 out of 4 patents)

11. Ji Yeon Park (3 out of 3 patents)

12. Bu Mahn Park (2 out of 2 patents)

13. Byeong-Deog Park (2 out of 2 patents)

14. Tae-Seong Kim (2 out of 5 patents)

15. Min Hee Kim (2 out of 2 patents)

20 patents: Sort by Forward Citations

1. 11744791 - Cosmetic composition comprising amide-based compound (2023-09-05),

2. 11607378 - Cosmetic composition comprising amide-based compound (2023-03-21),

3. 11471391 - Cosmetic composition for inhibiting sebum hypersecretion (2022-10-18),

4. 11446223 - Anti-aging composition (2022-09-20),

5. 11351131 - Anti-inflammatory composition (2022-06-07),

6. 11345655 - Pseudoceramide compound and skin external composition comprising the same (2022-05-31),

7. 11285119 - Anti-inflammatory composition (2022-03-29),

8. 11161822 - Amide compounds and use thereof (2021-11-02),

9. 10695275 - Anti-aging composition (2020-06-30),

10. 10016351 - Composition for promoting hair growth or preventing hair loss (2018-07-10),

11. 9867776 - Transdermal drug delivery system having multi-lamellar emulsion structure (2018-01-16),

12. 9796665 - Ceramide derivatives having agonistic effects on epidermal cannabinoid receptors, and pharmaceutical or cosmetic composition containing same (2017-10-24),

13. 9783489 - Pseudo ceramide compound, and pharmaceutical composition and cosmetic composition comprising same (2017-10-10),

14. 9744243 - Composition of external application to skin (2017-08-29),

15. 9512220 - Antibodies against angiopoietins 1 and 2, and their use (2016-12-06),

Company Overview

Neopharm Co., Ltd. is a South Korean company based in Daejeon, specializing in the development and manufacturing of innovative pharmaceutical products. The organization focuses on research in various therapeutic areas, including oncology and neurology, leveraging advanced technologies to enhance drug efficacy and safety. Neopharm is committed to improving patient outcomes through its dedication to quality and innovation in the pharmaceutical sector, contributing to the global healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

20 Patents

#40 in Daejeon

#635 in South Korea

#31,315 in the World

Daejeon, South Korea

Neopharm Co., Ltd.

Forward Citations = 22

50 inventors:

Bu-Mahn Park (11 out of 11 patents)

Hye Seong Shin (9 out of 9 patents)

Kyung Sook Yoo (8 out of 8 patents)

4. Se Kyoo Jeong (7 out of 9 patents)

5. Sung Woo Kim (4 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neopharm Co., Ltd.. Retrieved from https://idiyas.com/company/neopharm-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…